小鵬(09868.HK)被爆違反政策無法在上海申請「綠牌」 客服回應相關材料暫未提交
小鵬汽車-W(09868.HK)今早股價捱沽,盤中曾低見72.5元一度挫12.6%,最新報72.6元跌12.5%。
據《證券時報》報道,近日,有內地網友表示其購買的小鵬汽車-W(09868.HK)旗下車型在上海市新能源汽車專用牌照(綠牌)申領時,辦理狀態顯示審核不通過。其原因大概為違反上海市新能源辦的政策,從7月開始停止小鵬汽車生產的P7、P5等車型的新能源額度審批,具體恢復時間待定。
對此,小鵬汽車客服向媒體回應稱,已有一段時間,相關材料暫未提交。據了解,此事件是由於上海服務中心搬遷,相關信息未及時上傳系統,所以導致部分客戶的額度單審批失敗,現在已經全面恢復。(wl/k)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.